Myocardial Performance Index and Carotid Intima-Media Thickness in Children with Metabolically Healthy and

Nazlican Civilibal Tang1, Kazım Oztarhan2, Helen Bornaun3

  • 1Washington University School of Medicine, Department of Pediatrics, Division of Rheumatology and Immunology, St Louis, Missouri, United States; University of Health Sciences Türkiye, Kanuni Sultan Suleyman Training and Research Hospital, Clinic of Pediatrics, Istanbul, Türkiye

Insights

Obese children show higher myocardial performance index (MPI) and carotid intima-media thickness (cIMT) than non-obese peers. Metabolic health status in obese children did not significantly alter these cardiovascular risk markers.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Health
  • Obesity Research

Background:

  • Childhood obesity is a growing concern associated with cardiovascular risks.
  • Metabolic health status in obese children may influence cardiovascular outcomes.
  • Myocardial performance index (MPI) and carotid intima-media thickness (cIMT) are indicators of cardiovascular health.

Purpose of the Study:

  • To compare MPI and cIMT in metabolically healthy obese (MHO) and metabolically unhealthy obese (MUO) children with non-obese controls.
  • To investigate the association between obesity metrics and cardiovascular risk markers in children.

Main Methods:

  • Study included 62 obese children (6-17 years) and 30 healthy controls.
  • Obese children were categorized into MHO (n=32) and MUO (n=30) groups.
  • MPI and cIMT were measured and compared across groups. Body mass index-SDS and waist circumference-SDS were assessed.

Main Results:

  • Obese children exhibited significantly higher MPI and cIMT compared to controls.
  • No significant differences in MPI and cIMT were found between MHO and MUO groups.
  • Higher MPI correlated with BMI-SDS, and higher cIMT correlated with WC-SDS.

Conclusions:

  • Obesity in children, regardless of metabolic health, is linked to elevated cardiovascular risk.
  • MPI and cIMT are increased in obese children compared to healthy controls.
  • BMI-SDS and WC-SDS are valuable for identifying cardiovascular risk in pediatric obesity, highlighting the need for early interventions.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
58
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
52
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
620
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
216